Clinical outcome of triple-negative (TN) breast cancer (BC)

被引：0
|
作者：
Cabuk, D. [1 ]
Basaran, G. [1 ]
Kaya, H. [1 ]
Gulluoglu, B. [1 ]
Teomete, M. [1 ]
Dane, F. [1 ]
Yumuk, P. F. [1 ]
Turhal, N. S. [1 ]
机构：
[1] MUTFH, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.11526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11526
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cerebral metastases (CM) in breast cancer (BC) with focus on "triple-negative" (TN) tumors
    Heitz, F.
    Harter, P.
    Beutel, B.
    Lueck, H. J.
    Traut, A.
    du Bois, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S100 - S100
  • [2] Clinical outcome of triple-negative non-metastatic breast cancer
    Saeed, K.
    Mehmood, T.
    Hameed, S.
    Shah, M. Ali
    Jamshed, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S53 - S53
  • [3] CLINICAL OUTCOME OF TRIPLE-NEGATIVE BREAST CANCER IN YOUNGER AND OLDER WOMEN
    Haddad, S.
    Zemni, I.
    Bettaieb, I.
    Slimane, M.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A37 - A37
  • [4] Molecular comparison of human triple-negative inflammatory breast cancer (TN-IBC) and human triple-negative noninflammatory breast cancer (TN-non-IBC)
    Masuda, Hiroko
    Baggerly, Keith
    Wang, Ying
    Iwamoto, Takayuki
    Brewer, Takae
    Pusztai, Lajos
    Kai, Kazuharu
    Woodward, Wendy A.
    Reuben, James M.
    Van Laere, Steven J.
    Bertucci, Francois
    Hortobagyi, Gabriel N.
    Ueno, Naoto T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] A prognostic model for predicting breast cancer (BC)-related survival in operable triple-negative (TN) patients (pts)
    Munzone, Elisabetta
    Botteri, Edoardo
    Bagnardi, Vincenzo
    Sciandivasci, Angela
    Aurilio, Gaetano
    Adamoli, Laura
    Esposito, Angela
    Rotmensz, Nicole
    Goldhirsch, Aron
    Nole, Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Clinical characteristics of triple-negative breast cancer
    Hur, M. H.
    Im, R. J.
    Lee, S.
    Yoon, C. S.
    Ko, S. S.
    Lee, H.
    Kim, J. Y.
    Lee, J. H.
    Kang, S. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Platinum-based chemotherapy in triple-negative (TN) breast cancer
    Sirohi, B.
    Arnedos, M.
    Popat, S.
    Ashley, S.
    Nerurkar, A.
    Walsh, G.
    Johnston, S.
    Smith, I. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] The role of MRI in therapy management in triple-negative (TN) breast cancer
    Lex, B.
    Russu, V.
    Popovich, M.
    Gilster, T.
    Pfaffenberger, K.
    Volkholz, H.
    Tulusan, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Pathological characteristics and clinical outcome in triple-negative breast cancer (BC) patients (PTS): Results from the NORA study
    Cazzaniga, M. E.
    Mustacchi, G.
    Pronzato, P.
    Di Costanzo, F.
    De Matteis, A.
    Ravaioli, A.
    Gamucci, T.
    Brugia, M.
    Bari, M.
    Rulli, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Outcomes for metastatic triple-negative (TN) breast cancer: Impact for clinical practice and trial design
    Kassam, F.
    Enright, K.
    Dent, R.
    Flynn, C.
    Myers, J.
    Fralick, M.
    Kumar, R.
    Clemons, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345